Vitamin D for the management of multiple sclerosis.

CONCLUSIONS: To date, very low-quality evidence suggests no benefit of vitamin D for patient-important outcomes among people with MS. Vitamin D appears to have no effect on recurrence of relapse, worsening of disability measured by the Expanded Disability Status Scale (EDSS), and MRI lesions. Effects on health-related quality of life and fatigue are unclear. Vitamin D₃ at the doses and treatment durations used in the included trials appears to be safe, although available data are limited. Seven ongoing studies will likely provide further evidence that can be included in a future update of this review. PMID: 30246874 [PubMed - as supplied by publisher] (Source: Cochrane Database of Systematic Reviews)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2xPZNGI